Una visión integral del cáncer (II). Campos de estudio y biomarcadores emergentes

Noguera, Rosa; Burgos-Panadero, Rebeca; Gamero-Sandemetrio, Esther; Cruz-Merino, Luis de la; Álvaro Naranjo, Tomás.
Rev. esp. patol ; 52(4): 222-233, oct.-dic. 2019. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-191942

Documentos relacionados

  1. [An integral view of cancer (II). Fields of investigation and emerging biomarkers].
  2. CD10<sup>+</sup>GPR77<sup>+</sup> Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness.
  3. [Tissue biomarkers of response to anti-PD-1 immunotherapies in melanoma].
  4. Circulating tumor DNA and their added value in molecular oncology.
  5. Evaluation of Quantitative Relationship Between Target Expression and Antibody-Drug Conjugate Exposure Inside Cancer Cells.
  6. Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.
  7. MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition.
  8. Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer.
  9. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes.
  10. The tumor organismal environment: Role in tumor development and cancer immunotherapy.